Xeris Biopharma (XERS) Fair Value & DCF
Score
XERS fair value $17.07. Price $16.80. Price is about fair value.
Worked example
Cash-flow value $24.81 a share. The discount rate is 8.91% (beta 0.84). It is beta-adjusted and capped at 12%.
Earnings value. Next-twelve-months earnings per share of $0.34 times 27.31 is $9.34. The peer group is Biotechnology, 14 companies worth at least $10 billion. This stock has no 10-year median P/E, so the peer median of 27.3 is kept between 8 and 30, which is 27.31.
Fair value is the average of the two, $17.07. The price is $16.80, which is 1.6% below fair value.